CardioVascular Dynamics CE-marks Synthesis STAR coronary stents:
This article was originally published in Clinica
CardioVascular Dynamics of Irvine, California, will market its range of Synthesis STAR coronary stents in Europe. This new generation combines the flexible stent technology used in the Synthesis product line with the focus catheter technology used in the STAR product line.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.